167 related articles for article (PubMed ID: 7827902)
81. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
[TBL] [Abstract][Full Text] [Related]
82. Positron emission tomography for evaluation of colorectal carcinoma.
Vitola J; Delbeke D
Semin Roentgenol; 2002 Apr; 37(2):118-28. PubMed ID: 12134365
[TBL] [Abstract][Full Text] [Related]
83. Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases.
Topal B; Flamen P; Aerts R; D'Hoore A; Filez L; Van Cutsem E; Mortelmans L; Penninckx F
Eur J Surg Oncol; 2001 Mar; 27(2):175-9. PubMed ID: 11345944
[TBL] [Abstract][Full Text] [Related]
84. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
85. Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Lonneux M; Delval D; Bausart R; Moens R; Willockx R; Van Mael P; Declerck P; Jamar F; Zreik H; Pauwels S
Nucl Med Commun; 1998 Nov; 19(11):1047-54. PubMed ID: 9861621
[TBL] [Abstract][Full Text] [Related]
86. Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
Gupta N; Bradfield H
Semin Nucl Med; 1996 Jan; 26(1):65-73. PubMed ID: 8623053
[TBL] [Abstract][Full Text] [Related]
87. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging.
Schiepers C; Penninckx F; De Vadder N; Merckx E; Mortelmans L; Bormans G; Marchal G; Filez L; Aerts R
Eur J Surg Oncol; 1995 Oct; 21(5):517-22. PubMed ID: 7589597
[TBL] [Abstract][Full Text] [Related]
88. [Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer].
Schlag PM; Amthauer H; Stroszczynski C; Felix R
Chirurg; 2001 Sep; 72(9):995-1002. PubMed ID: 11594285
[TBL] [Abstract][Full Text] [Related]
89. PET/CT in oncology: for which tumours is it the reference standard?
Collins CD
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S77-87. PubMed ID: 17921085
[TBL] [Abstract][Full Text] [Related]
90. PET scans of abdominal malignancy.
Blahd WH; Brown CV; Khonsary SA; Farahi JB; Quinones N; Ribe JY; Coyle JJ; Glass EC; Mandelkern MA
World J Surg; 1996 Feb; 20(2):245-7. PubMed ID: 8661826
[TBL] [Abstract][Full Text] [Related]
91. Positron emission tomography affects surgical management in recurrent colorectal cancer patients.
Desai DC; Zervos EE; Arnold MW; Burak WE; Mantil J; Martin EW
Ann Surg Oncol; 2003; 10(1):59-64. PubMed ID: 12513962
[TBL] [Abstract][Full Text] [Related]
92. Positron emission tomography scanning is coming to a hospital near you soon!
Bashir H; Shabo G; Nunan TO
Clin Med (Lond); 2008 Apr; 8(2):134-9. PubMed ID: 18478853
[TBL] [Abstract][Full Text] [Related]
93. The role of positron emission tomography in the management of colorectal cancer.
Tutt AN; Plunkett TA; Barrington SF; Leslie MD
Colorectal Dis; 2004 Jan; 6(1):2-9. PubMed ID: 14692944
[TBL] [Abstract][Full Text] [Related]
94. Whole-body PET proves superior to CT for staging primary colorectal carcinoma.
Ott DJ
Am J Gastroenterol; 1999 Jan; 94(1):285-6. PubMed ID: 9934781
[No Abstract] [Full Text] [Related]
95. PET in colorectal cancer.
Dresel S; Schlag PM
Recent Results Cancer Res; 2008; 170():109-24. PubMed ID: 18019621
[No Abstract] [Full Text] [Related]
96. Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases.
Schüssler-Fiorenza CM; Mahvi DM; Niederhuber J; Rikkers LF; Weber SM
J Gastrointest Surg; 2004 Feb; 8(2):150-7; discussion 157-8. PubMed ID: 15036190
[TBL] [Abstract][Full Text] [Related]
97. The expanding role of PET technology in the management of patients with colorectal cancer.
Herbertson RA; Lee ST; Tebbutt N; Scott AM
Ann Oncol; 2007 Nov; 18(11):1774-81. PubMed ID: 17434894
[TBL] [Abstract][Full Text] [Related]
98. [Localization of a tumor of unknown origin by means of 18-fluorodeoxyglucose positron emission tomography].
Ortega A; Pérez-Castejón MJ; Jiménez-Vicioso A; Expósito R; Domper M; Montz R; Carreras JL
Rev Clin Esp; 2000 Aug; 200(8):457-9. PubMed ID: 11076189
[No Abstract] [Full Text] [Related]
99. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer.
Johnson K; Bakhsh A; Young D; Martin TE; Arnold M
Dis Colon Rectum; 2001 Mar; 44(3):354-7. PubMed ID: 11289280
[TBL] [Abstract][Full Text] [Related]
100. [Massive liver metastases from colorectal cancer].
Figueras J
Cir Esp; 2005 Jun; 77(6):313-4. PubMed ID: 16420942
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
